EM Review: Risk Assets Rose on Drug Optimism, Easing Lockdowns

(Bloomberg) -- Emerging-market stocks just had their best month in four years amid optimism that scientists are making progress toward a drug to treat the coronavirus and as nations began to roll b...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.